logo

iStock Rating

A
Details...
Enter Symbol click to research

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)

Sector: Medical

Current Price : $7.51

52 Week Low
$7.2152 Week High
$11.81
 

ARENA PHAR(NSDQ:ARNA)
Arena Pharmaceuticals, Inc. a biotechnology company that has developed CART, a new technology which they use to identify new drug candidates more efficiently than traditional drug discovery techniques. Using CART, they have discovered new drug candidates in the areas of obesity and schizophrenia. Based on the success using CART, they have established collaborative drug discovery programs with a number of pharmaceutical and biotechnology companies.
# Employees: 293
Address: 6154 NANCY RIDGE DRIVE,SAN DIEGO,CA,USA
Phone: 858-453-7200
Fax: 858-453-7210
Website: http://www.arenapharm.com
Email: invest@arenapharm.com
Sector: Medical
Industry: MED-BIOMED/GENE
Executive Officers
Jack Lief (Chairman; President and Chief Executive Officer)
Robert E. Hoffman (Senior Vice President; Finance and Chief Financial)
Dominic P. Behan (Ph.D.)
Director (Donald D. Belcher)
Director (Scott H. Bice ,Director,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 3/31/2013
Next Earnings Date(Expected): 8/8/2013
Mean EPS (Next Qtr): $0.12
Mean EPS (Year): ($0.12)
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 7
Shares Performance
Period arna Compare to S&P
YTD -13.75 % -24.38 %
4 Weeks -2.51 % -0.06 %
12 Weeks -7.27 % -11.25 %
Shares Information
Analyst Coverage: Y
Avg Volume: 5222659
Shares Outstanding: 217M
Market Cap: $1.69B
52 Week High: $11.81
52 Week Low: $7.21
P/E Ratio: -0.010
PEG Ratio: -0.010
Split: On 1/1/1990 arna split by factor of 0.070
Earnings Performance
EPS Growth in Last Quarter: 10.00 %
EPS Growth in Last Year: 40.00 %
Sales Growth in Last Quarter: 22.57 %
Sales Growth in Last Quarter: 8.41 %
Financials
Qtr Book Value: $21.04
Cash Flow/Share: ($0.01)
Change in Payout Ratio: -0.010
Price/Sales: 61.010
Home | Login |Research | Earnings | Scans | Stock Charts | Chart School | Glossary |Submit Article | Join Blog Network | Advertise | Subscribe to RSS

Terms of Use | Privacy Policy | Copyright 2012 all rights reserved
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.